A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

Clinical trial NCT05960708 · COMPLETED

Trial details

NCT number: NCT05960708
Sponsor: Yuhan Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allergic Disease Chronic Spontaneous Urticaria Chronic Inducible Urticaria Cold Urticaria

Start date: 2023-08-23
Primary completion: 2024-09-13
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.